Nanomedicine: Nanotechnology, Biology and Medicine
Volume 6, Issue 5 , Pages 698-705, October 2010

Cerium oxide nanoparticles protect gastrointestinal epithelium from radiation-induced damage by reduction of reactive oxygen species and upregulation of superoxide dismutase 2

  • Jimmie Colon, MS

      Affiliations

    • M.D. Anderson Cancer Center Orlando, Cancer Research Institute, Orlando, Florida, USA
  • ,
  • Nelson Hsieh

      Affiliations

    • M.D. Anderson Cancer Center Orlando, Cancer Research Institute, Orlando, Florida, USA
  • ,
  • Amber Ferguson

      Affiliations

    • M.D. Anderson Cancer Center Orlando, Cancer Research Institute, Orlando, Florida, USA
  • ,
  • Patrick Kupelian, MD

      Affiliations

    • M.D. Anderson Cancer Center Orlando, Department of Radiation Oncology, Orlando, Florida, USA
  • ,
  • Sudipta Seal, PhD

      Affiliations

    • Department of Mechanical, Materials and Aerospace Engineering, Advanced Materials Processing and Analysis Center (AMPAC), University of Central Florida, Orlando, Florida, USA
    • Nanoscience and Technology Center, University of Central Florida, Orlando, Florida, USA
  • ,
  • D. Wayne Jenkins, MD

      Affiliations

    • M.D. Anderson Cancer Center Orlando, Department of Radiation Oncology, Orlando, Florida, USA
  • ,
  • Cheryl H. Baker, PhD

      Affiliations

    • M.D. Anderson Cancer Center Orlando, Cancer Research Institute, Orlando, Florida, USA
    • Burnett School of Biomedical Sciences, University of Central Florida, Orlando, Florida, USA
    • Corresponding Author InformationCorresponding author: Cancer Research Institute at M.D. Anderson Cancer Center Orlando, Orlando, Florida 32827, USA.

Received 20 July 2009; accepted 25 January 2010. published online 22 February 2010.

Abstract 

The ability of rare earth cerium oxide (CeO2) nanoparticles to confer radioprotection against gastrointestinal epithelium was examined. The pretreatment of normal human colon cells (CRL 1541) with varying concentrations of CeO2 nanoparticles 24 hours before single-dose radiation exposure conferred protection from radiation-induced cell death by reducing the amount of reactive oxygen species produced and increasing the expression of superoxide dismutase 2 (SOD2), in a dose-dependent manner. In subsequent experiments athymic nude mice were pretreated with intraperitoneal injections of CeO2 nanoparticles before a single dose of radiation to the abdominal area. Immunohistochemical analysis show a decrease in TUNEL-and caspase 3–positive cells in the colonic crypt, 4 hours after radiation. In sharp contrast, a significant increase in SOD2 expression was observed. In the end, these studies suggest that CeO2 nanoparticles protect the gastrointestinal epithelium against radiation-induced damage by (1) acting as free-radical scavengers and (2) increasing the production of SOD2 before radiation insult.

From the Clinical Editor

In this study, the ability of rare earth cerium oxide (CeO2) nanoparticles to confer radioprotection was examined. The results suggest that CeO2 nanoparticles protect the gastrointestinal epithelium against radiation-induced damage both by acting as free-radical scavengers and by increasing the production of SOD2 before radiation insult.

Key words: Cerium oxide nanoparticles, Radioprotection, SOD2, Gastrointestinal epithelium

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 This collaboration was made possible through the support of the M. D. Anderson Cancer Center Orlando, University of Central Florida, and the National Science Foundation.

PII: S1549-9634(10)00017-1

doi:10.1016/j.nano.2010.01.010

Nanomedicine: Nanotechnology, Biology and Medicine
Volume 6, Issue 5 , Pages 698-705, October 2010